SCHEMBL6318668

SCHEMBL6318668

CCOC(=O)c1cn(C)c2c(CBr)csc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.43
BAZ2A Q9UIF9 1/20 0.43
TDP1 Q9NUW8 1/20 0.39
STAT3 P40763 1/20 0.39
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 6/20 0.38
HTT P42858 2/20 0.38
CYP1A2 P05177 1/20 0.38
LMNA P02545 1/20 0.37
NR1H2 P55055 1/20 0.37
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
HSD17B10 Q99714 4/20 0.35
HPGD P15428 3/20 0.35
RECQL P46063 1/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317490 0.85 BAZ2B (0.47) BAZ2BBAZ2ATDP1STAT3ALDH1A1
SCHEMBL9834486 0.81 BAZ2B (0.44) BAZ2BBAZ2ATDP1STAT3ALDH1A1
SCHEMBL6318082 0.72 ALDH1A1 (0.47) BAZ2BBAZ2ATDP1STAT3ALDH1A1
SCHEMBL6050604 0.72 BAZ2B (0.47) BAZ2BBAZ2ATDP1ALDH1A1KDM4E
SCHEMBL6317607 0.71 BAZ2B (0.43) BAZ2BBAZ2ATDP1STAT3ALDH1A1
SCHEMBL28346320 0.71 BAZ2B (0.51) BAZ2BBAZ2ATDP1STAT3ALDH1A1
SCHEMBL9837365 0.69 BAZ2B (0.53) BAZ2BBAZ2ASTAT3ALDH1A1KDM4E
SCHEMBL9837457 0.68 TSHR (0.35) BAZ2BBAZ2AALDH1A1KDM4EHTT
SCHEMBL9835705 0.68 BAZ2B (0.54) BAZ2BBAZ2ASTAT3ALDH1A1KDM4E
SCHEMBL7111537 0.67 BAZ2B (0.47) BAZ2BBAZ2ATDP1STAT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6852731-B2 Antiviral compounds PFIZER (US) 2005-02-08 US disclosed
US-20040242884-A1 ANTIVIRAL COMPOUNDS PHARMACIA & UPJOHN COMPANY 2004-12-02 US disclosed
EP-1472260-A2 THIENO(3,2-B)PYRIDONES AS ANTIVIRAL COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 2004-11-03 EP disclosed
WO-2003059878-A2 THIENO (3, 2-B) PYRIDONES AS ANTIVIRAL COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242884-A1 ANTIVIRAL COMPOUNDS ZC3HAV1, IRF3, IFNAR1 BAZ2B 3271/4885BAZ2A 3412/4885TDP1 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.